Back to Search Start Over

Pathogenic autoantibodies to IFN-γ act through the impedance of receptor assembly and Fc-mediated response.

Authors :
Shih HP
Ding JY
Sotolongo Bellón J
Lo YF
Chung PH
Ting HT
Peng JJ
Wu TY
Lin CH
Lo CC
Lin YN
Yeh CF
Chen JB
Wu TS
Liu YM
Kuo CY
Wang SY
Tu KH
Ng CY
Lei WT
Tsai YH
Chen JH
Chuang YT
Huang JY
Rey FA
Chen HK
Chang TW
Piehler J
Chi CY
Ku CL
Source :
The Journal of experimental medicine [J Exp Med] 2022 Sep 05; Vol. 219 (9). Date of Electronic Publication: 2022 Jul 14.
Publication Year :
2022

Abstract

Anti-interferon (IFN)-γ autoantibodies (AIGAs) are a pathogenic factor in late-onset immunodeficiency with disseminated mycobacterial and other opportunistic infections. AIGAs block IFN-γ function, but their effects on IFN-γ signaling are unknown. Using a single-cell capture method, we isolated 19 IFN-γ-reactive monoclonal antibodies (mAbs) from patients with AIGAs. All displayed high-affinity (KD < 10-9 M) binding to IFN-γ, but only eight neutralized IFN-γ-STAT1 signaling and HLA-DR expression. Signal blockade and binding affinity were correlated and attributed to somatic hypermutations. Cross-competition assays identified three nonoverlapping binding sites (I-III) for AIGAs on IFN-γ. We found that site I mAb neutralized IFN-γ by blocking its binding to IFN-γR1. Site II and III mAbs bound the receptor-bound IFN-γ on the cell surface, abolishing IFN-γR1-IFN-γR2 heterodimerization and preventing downstream signaling. Site III mAbs mediated antibody-dependent cellular cytotoxicity, probably through antibody-IFN-γ complexes on cells. Pathogenic AIGAs underlie mycobacterial infections by the dual blockade of IFN-γ signaling and by eliminating IFN-γ-responsive cells.<br /> (© 2022 Shih et al.)

Details

Language :
English
ISSN :
1540-9538
Volume :
219
Issue :
9
Database :
MEDLINE
Journal :
The Journal of experimental medicine
Publication Type :
Academic Journal
Accession number :
35833912
Full Text :
https://doi.org/10.1084/jem.20212126